Weekly Roundup: December 7, 2018
Dec 07, 2018•10 min
Episode description
This week, the team discuss Novartis' AVXS-101 FDA application; the UK regulators' promise to review its HTA system under a new voluntary pricing and access scheme and clinical trial updates from bluebirdbio’s gene therapy LentiGlobin.
Presenter: Joanna Fernandes
Contributor: Aparna Krishnan
For the best experience, listen in Metacast app for iOS or Android
